A recent lightning rod for abortion opponents, the drug mifepristone—the first of two in the standard medication abortion regimen—surfaced several times during Robert F. Kennedy, Jr.’s first Senate confirmation hearing as President Trump’s pick for Health and Human Services secretary.

Robert F. Kennedy Jr had an absolute trainwreck of a confirmation hearing. Kennedy, who had been a vocal vaccine skeptic and preached numerous disproven conspiracy theories, was lambasted for his anti-science stance and his refusal to stop suing the very companies he now wants to regulate.

Missouri, Kansas and Idaho can press forward with their lawsuit to restrict access to the abortion drug mifepristone, a federal judge ruled Thursday, months after the US Supreme Court had rejected an earlier version of the legal challenge.

Meanwhile, in an executive order, Trump created his long-discussed “Department of Government Efficiency,” to be led by Elon Musk, the world’s richest man. On paper, the department is tasked with modernizing federal technology and software; however, Trump and Musk have spent months boasting about how it will gut the federal government.

Three Republican-led states will be allowed to move forward with a lawsuit to restrict access to mifepristone, a Texas federal judge ruled Thursday, months after the Supreme Court rejected an

A higher dose of an emergency-contraception drug may open a back door for Americans seeking abortions in restrictive states.

Last Friday, my colleague Julianne McShane and I broke the news of a pair of letters sent by 30 prominent anti-abortion movement leaders to the heads of the Departments of Health and Human Services and Justice, asking them to use the powers of their agencies to attack abortion pills.

A new study shows a possible new abortion drug to replace mifepristone. But will these results increase abortion access—or restrict women's reproductive health options down the line?

A decision by a federal judge last week is reviving the effort to limit access to mifepristone, opening a fresh round of litigation over a widely used drug that has grown in importance since the ...

Abortion opponents praised Robert F. Kennedy Jr. on Wednesday, after he vowed at a Senate hearing to implement "whatever" position President Trump takes on regulating abortion pills, if confirmed as the next secretary of health and human services.

Robert F. Kennedy Jr. made several disturbing comments during his first Senate confirmation hearing Wednesday suggesting that, as Donald Trump’s secretary of health and human services, he’s hoping to limit access to the abortion pill mifepristone.

Robert F. Kennedy Jr. was pressed to clarify his views on vaccines, abortion, and public health priorities in his first Senate hearing.